SOTERA HEALTH COMPANY Operating Lease Cost
SOTERA HEALTH COMPANY (SHC) reported Operating Lease Cost of $13.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-24
- SOTERA HEALTH COMPANY operating lease, cost for fiscal 2025 was $13.21M, a 0.45% decline from fiscal 2024.
- SOTERA HEALTH COMPANY operating lease, cost for fiscal 2024 was $13.27M, a 4.69% decline from fiscal 2023.
- SOTERA HEALTH COMPANY operating lease, cost for fiscal 2023 was $13.92M, a 7.95% decline from fiscal 2022.
- SOTERA HEALTH COMPANY operating lease, cost for fiscal 2022 was $15.12M, a 2.02% decline from fiscal 2021.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $13.21M 10-K · filed 2026-02-24 |
| 2024-12-31 | $13.27M 10-K · filed 2026-02-24 |
| 2023-12-31 | $13.92M 10-K · filed 2026-02-24 |
| 2022-12-31 | $15.12M 10-K · filed 2025-02-27 |
| 2021-12-31 | $15.43M 10-K · filed 2024-02-27 |
| 2020-12-31 | $14.40M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |